OncoVerity

OncoVerity uses advanced bioinformatics to develop cancer therapies. They leverage a computational approach to inform drug development strategies, focusing on addressing unmet medical needs in cancer patients. Their current focus is on advancing cusatuzumab, a novel antibody for treating acute myeloid leukemia (AML).

Buy Funded Startups lists

Funding Round: Series A+

Funding Amount:

Date: 21-Nov-2024

Investors: argenx, RefinedScience

Markets: Biotechnology, Oncology, Therapeutics

HQ: Aurora, Colorado, United States

Founded: 2022

Website: https://www.oncoverity.com/

LinkedIn: https://www.linkedin.com/company/oncoverity-inc

Twitter:

Instagram: